Evidence map›Paper›PMID 35550662›Full record

ArticleCell host & microbe2022

RTS,S today and tomorrow's science.

Nginache Nampota Nkomba, Cristiana Cairo, Miriam K Laufer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell host & microbe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nginache Nampota NkombaBlantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.
Cristiana CairoInstitute for Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: ccairo@ihv.umaryland.edu.
Miriam K LauferCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: mlaufer@som.umaryland.edu.

Funding

The impact of in utero HIV exposure on infant T and B cell responses in MalawiU01HD092308 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI CAIRO, CRISTIANA, LAUFER, MIRIAM K. · 2017 to 2021
$2.7M
Mentoring in patient-oriented research in global healthK24AI114996 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LAUFER, MIRIAM K. · 2016 to 2025
$1.6M
NIAID NIH HHS K24 AI114996NICHD NIH HHS U01 HD092308
6 · The paper itself

Abstract

The first malaria vaccine has been recently approved for children living in malaria-endemic areas. While this is long-awaited and welcome news, the modest efficacy of the vaccine highlights several areas that require further attention. Here, we describe the likely impact of the vaccine and where clinical and basic discovery research will still be required.

Indexed as

MalariaMalaria, FalciparumMalaria VaccinesChildHumansInfantPlasmodium falciparumMalaria Vaccines

Identifiers

PMID35550662
PMCPMC10317573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.